Back to results
US 2025/0375517 A1Published application
Peanut formulations and uses thereof
AssigneeSociete des Produits Nestle S.A.
InventorsBryan WALSER, Howard V. RAFF
Life of this patent
Estimating the term…
Abstract
The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
Claims23
1-55. (canceled)
A composition comprising:
- (a) defatted peanut flour comprising peanut protein in an amount of:
- (i) 0.45 mg to 0.5 mg;
- (ii) 0.9 mg to 1.1 mg;
- (iii) 9 mg to 11 mg;
- or
- (iv) 18 mg to 22 mg;
- wherein the peanut protein comprises proteins Ara h1, Ara h2, and Ara h6;
- (b) microcrystalline cellulose in an amount of from 60% to 90% w/w of the composition;
- (c) pregelatinized starch in an amount of from 5% to 20% w/w of the composition;
- (d) colloidal anhydrous silica in an amount of from 0.01% to 1% w/w of the composition;
- and
- (e) magnesium stearate in an amount of from 0.01% to 1% w/w of the composition,
- wherein the composition is encapsulated in a hydroxypropyl methylcellulose (HPMC) capsule that is configured to be opened.
10 more elements
A composition comprising:
- (a) defatted peanut flour comprising peanut protein in an amount of 90 mg to 110 mg, wherein the peanut protein comprises proteins Ara h1, Ara h2, and Ara h6;
- (b) microcrystalline cellulose in an amount of from 60% to 90% w/w of the composition;
- (c) colloidal anhydrous silica in an amount of from 0.01% to 1% w/w of the composition;
- and
- (d) magnesium stearate in an amount of from 0.01% to 1% w/w of the composition,
- wherein the composition is encapsulated in a hydroxypropyl methylcellulose (HPMC) capsule that is configured to be opened.
3 more elements
A composition comprising:
- (a) defatted peanut flour comprising peanut protein in an amount of 270 mg to 330 mg, wherein the peanut protein comprises proteins Ara h1, Ara h2, and Ara h6;
- (b) microcrystalline cellulose in an amount of from 60% to 90% w/w of the composition;
- (c) colloidal anhydrous silica in an amount of from 0.01% to 1% w/w of the composition;
- and
- (d) magnesium stearate in an amount of from 0.01% to 1% w/w of the composition,
- wherein the composition is a dispensable powder.
3 more elements
Dependencies are inferred from the claim text.